069620.KS
Daewoong pharmaceutical Co.,Ltd
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 114,800.00
−7.49%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- —
- Revenue estimate
- KRW 445.1B
Latest reported
- Last report date
- Jul 29, 2026
- EPS actual
- KRW 1.7K
- EPS estimate
- —
- Revenue actual
- KRW 424.4B
- Revenue estimate
- KRW 406.4B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- 2
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026